Navigation Links
Tour DaVita Rides to Improve Kidney Disease Education
Date:9/10/2008

Cycling Event to Raise Funds for Kidney Disease Awareness and Prevention

Programs

EL SEGUNDO, Calif., Sept. 10 /PRNewswire/ -- Currently more than 26 million Americans are affected by chronic kidney disease (CKD). Among them, nine in ten do not realize it and are not aware of the potential consequences. DaVita Inc., a leading provider of kidney care services in the United States, is taking action to help combat this silent killer by creating much needed awareness and raising contributions. The fundraising, bike ride event, called Tour DaVita(TM), aims to increase awareness of chronic kidney disease as its participants cycle through several cities across the state of Wis. The ride will kick-off on September 15th in New London, Wis., and will cross the finish line four days later in the town of Algoma. Its goal is to raise funds in order to fight CKD. More than 230 DaVita(R) teammates (employees) will hop on their bikes and ride approximately 240 miles over the course of the four day tour. Funds raised by the bike ride will benefit The Kidney TRUST(TM), a non-profit organization aimed at prevention and awareness of CKD.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

DaVita CEO Kent Thiry will be participating in the ride with his teammates as the tour travels through Wis. A native of the state, Thiry said: "This is one of the most important events of the year for our community. It is our way to express our dedication and commitment to our patients through continued education and awareness. Our teammates have worked incredibly hard both training and fundraising for this cause, and I'm honored to be a part of it with them."

Initial stages of CKD rarely show symptoms and there is no cure for the disease. However, if it is caught early enough healthy therapies that can slow the disease's progress can be more effective. DaVita teammates participating in the ride intend to stress the importance of obtaining early testing to avoid advanced CKD, which may require dialysis treatment or a kidney transplant.

DaVita and Tour DaVita are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About The Kidney TRUST

The Kidney TRUST was founded in 2006 by DaVita Inc. The Kidney TRUST is an independent, non-profit organization that believes everyone should be empowered to take a proactive role in their health. Toward that end, the Kidney TRUST is seeking to reduce the advancement of chronic kidney disease (CKD) by broadly deploying cost-effective rapid-screening for CKD in non-medical settings, and providing financial assistance to people affected by CKD. For more information, visit http://www.kidneytrust.org.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials, and its community programs, please visit http://www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Dietitians to Speak at the International Congress on Nutrition and Metabolism in Renal Disease in France
2. DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards
3. DaVita Renal Dietitians Conduct First-Ever EYE on CKD Workshop
4. DaVita Board of Directors Increases Share Repurchase Authorization
5. DaVita 4th Quarter 2007 Results
6. DaVita Announces Chief Financial Officer
7. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
8. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
9. DaVita Inc. to Present at JPMorgan Healthcare Conference
10. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
11. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... ... June 28, 2017 , ... Anyone with a remote control has seen the never-ending twists on ... the flipper will get rich in no time. But what about the buyers of ... for the buyer of a flipped house. An email recently sent to Gary Case ...
(Date:6/28/2017)... ... 2017 , ... Park Systems , a leader in Atomic Force Microscopy ... attendees and Park customers on July 11, 2017 from 12-2pm at the Thirsty Bear ... CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor in the ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences ... Company specializing in the development of cannabinoid-based drugs, ... a company overview at three upcoming scientific and ... Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: